Early stage breast cancer has a better prognosis in early stage with timely and reasonable treatment. Early stage breast cancer is divided into pathological early stage cancer and clinical early stage cancer. The most common types of early-stage breast cancer include intraductal carcinoma, lobular carcinoma in situ, papillary Paget’s disease without masses, and microscopic early invasive carcinoma with only punctate basement membrane invasion. Early clinical stage carcinoma includes tumors that are not clinically accessible or small breast cancer with a maximum diameter of less than 2 cm and no lymph node metastasis. However, theoretically speaking, it is inaccurate to classify the early stage of cancer by the size of tumor diameter, and a tumor less than 2 cm in diameter is not necessarily an early stage cancer. And T0N0M0 or T1N0M0 is only the early stage of breast cancer in patients. At present, there are also more scholars who believe that the prognosis of early stage clinical cancer should be viewed longitudinally, regardless of the size of the lump, and its long-term tumor-free survival rate after local treatment is higher than 90%, which can also become early stage breast cancer. Chinese medicine has accumulated many very effective treatment methods in long-term clinical practice. Drugs used in conjunction can shrink the lump in the short term, control metastasis and spread, reduce pain, stabilize the disease, prolong survival, can effectively control the metastasis and spread of cancer cells, can enhance the body’s immune function in order to inhibit the growth of cancer cells, enhance the body’s immunity and prevent the spread of metastasis.